Caffeic Acid Combining High-dose Dexamethasone in Management of ITP
Status:
Completed
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
The project was undertaking by Qilu Hospital of Shandong University in China. In order to
report the efficacy and safety of caffeic acid tablets combining with high-dose dexamethasone
for the treatment of adults with newly-diagnosed primary immune thrombocytopenia (ITP).